Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

NCT00055991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bexarotene

Sponsor

Baylor Breast Care Center

Collaborators

[object Object]